Medical experts emphasize that GLP-1 weight-loss medications require comprehensive lifestyle changes and medical supervision to achieve sustained results. Nearly 1 in 5 people have taken GLP-1s at some point, according to research from KFF, a health information nonprofit. However, doctors stress that regular exercise, smart food choices, and adequate sleep are essential complements to medication for achieving long-term weight goals. Obesity medicine physician Dafina Allen noted that some people reduce their caloric intake while taking GLP-1s but do not improve their overall health because they neglect exercise or food quality.
One patient’s experience illustrates this reality. Jelon Smart, a 48-year-old caterer in Savannah, Georgia, started taking GLP-1 Ozempic when severe ankle pain from Achilles tendinitis motivated her to address her weight of 285 pounds. She initially lost 30 pounds without lifestyle changes, but when weight loss plateaued, she added six days a week of gym exercise and eventually reached 175 pounds. As her weight decreased, the swelling and pain in her ankle resolved. Mental health also plays a crucial role in long-term success. Allen noted that some patients lose significant amounts of weight—50 to 100 pounds—but still struggle with body image and self-acceptance, underscoring the importance of mental health support alongside medication.
Safety and Access Concerns
Internal medicine physician Gerald Onuoha cautioned that patients face serious complications when they increase GLP-1 dosage too quickly or fail to follow recommended schedules, including pancreatitis, gallstones, and acute kidney injury. A significant challenge is access through online pharmacies, where patients may not receive proper medical education about dosage or whether the medication is safe given their medical conditions. Allen emphasized that GLP-1s are “relatively easy to access and often much cheaper” through online providers, but this convenience comes without proper medical oversight. Most insurance programs do not cover GLP-1s for weight loss, though Medicaid covers the medications for diabetes. Only about a dozen state Medicaid programs cover GLP-1s specifically for obesity treatment. The federal government is planning temporary Medicare coverage of GLP-1s for weight loss starting in July.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.columbian.com/news/2026/apr/14/doctors-glp-1-weight-loss-drugs-cant-do-it-alone/